Nonmedical Opioid Prescription Use Among Transgender Girls, Young Women

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 16, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.1015?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031620

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

What The Study Did: This observational study looked at how common nonmedical prescription opioid use was among transgender girls and young women and risk factors associated with it.

Authors: Arjee J. Restar, M.P.H., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author.

 

(10.1001/jamanetworkopen.2020.1015)

Editor’s Note: The article includes conflict of interest and funding support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.